rs55747230

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001042492.3(NF1):​c.8113+20G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0176 in 1,613,800 control chromosomes in the GnomAD database, including 301 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 22 hom., cov: 32)
Exomes 𝑓: 0.018 ( 279 hom. )

Consequence

NF1
NM_001042492.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 1.62
Variant links:
Genes affected
NF1 (HGNC:7765): (neurofibromin 1) This gene product appears to function as a negative regulator of the ras signal transduction pathway. Mutations in this gene have been linked to neurofibromatosis type 1, juvenile myelomonocytic leukemia and Watson syndrome. The mRNA for this gene is subject to RNA editing (CGA>UGA->Arg1306Term) resulting in premature translation termination. Alternatively spliced transcript variants encoding different isoforms have also been described for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 17-31358642-G-A is Benign according to our data. Variant chr17-31358642-G-A is described in ClinVar as [Benign]. Clinvar id is 257306.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-31358642-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.0137 (2081/152296) while in subpopulation AMR AF= 0.0207 (316/15300). AF 95% confidence interval is 0.0188. There are 22 homozygotes in gnomad4. There are 1032 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 2081 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NF1NM_001042492.3 linkuse as main transcriptc.8113+20G>A intron_variant ENST00000358273.9 NP_001035957.1
NF1NM_000267.3 linkuse as main transcriptc.8050+20G>A intron_variant NP_000258.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NF1ENST00000358273.9 linkuse as main transcriptc.8113+20G>A intron_variant 1 NM_001042492.3 ENSP00000351015 P1P21359-1

Frequencies

GnomAD3 genomes
AF:
0.0137
AC:
2081
AN:
152178
Hom.:
22
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00408
Gnomad AMI
AF:
0.0143
Gnomad AMR
AF:
0.0206
Gnomad ASJ
AF:
0.00778
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000620
Gnomad FIN
AF:
0.0217
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0191
Gnomad OTH
AF:
0.0110
GnomAD3 exomes
AF:
0.0132
AC:
3325
AN:
251088
Hom.:
36
AF XY:
0.0132
AC XY:
1797
AN XY:
135698
show subpopulations
Gnomad AFR exome
AF:
0.00406
Gnomad AMR exome
AF:
0.0123
Gnomad ASJ exome
AF:
0.00626
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000621
Gnomad FIN exome
AF:
0.0232
Gnomad NFE exome
AF:
0.0190
Gnomad OTH exome
AF:
0.0162
GnomAD4 exome
AF:
0.0180
AC:
26258
AN:
1461504
Hom.:
279
Cov.:
31
AF XY:
0.0175
AC XY:
12749
AN XY:
727058
show subpopulations
Gnomad4 AFR exome
AF:
0.00367
Gnomad4 AMR exome
AF:
0.0131
Gnomad4 ASJ exome
AF:
0.00605
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.000557
Gnomad4 FIN exome
AF:
0.0236
Gnomad4 NFE exome
AF:
0.0208
Gnomad4 OTH exome
AF:
0.0152
GnomAD4 genome
AF:
0.0137
AC:
2081
AN:
152296
Hom.:
22
Cov.:
32
AF XY:
0.0139
AC XY:
1032
AN XY:
74478
show subpopulations
Gnomad4 AFR
AF:
0.00407
Gnomad4 AMR
AF:
0.0207
Gnomad4 ASJ
AF:
0.00778
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000414
Gnomad4 FIN
AF:
0.0217
Gnomad4 NFE
AF:
0.0191
Gnomad4 OTH
AF:
0.0109
Alfa
AF:
0.0144
Hom.:
6
Bravo
AF:
0.0135

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpAug 12, 2019Variant summary: NF1 c.8050+20G>A alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.013 in 251088 control chromosomes, predominantly at a frequency of 0.019 within the Non-Finnish European subpopulation in the gnomAD database, including 25 homozygotes. The observed variant frequency within Non-Finnish European control individuals in the gnomAD database is approximately 8000-folds over the estimated maximal expected allele frequency for a pathogenic variant in NF1 causing Noonan Syndrome and Related Conditions phenotype (2.5e-06), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Non-Finnish European origin. Two ClinVar submissions (evaluation after 2014) cite the varinat as benign. Based on the evidence outlined above, the variant was classified as benign. -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingCenter for Genomic Medicine, Rigshospitalet, Copenhagen University HospitalJul 30, 2022- -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingGeneDxApr 08, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 09, 2023- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Neurofibromatosis, type 1 Benign:2
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabMar 15, 2022- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Neurofibromatosis, familial spinal Benign:1
Benign, criteria provided, single submitterclinical testingKCCC/NGS Laboratory, Kuwait Cancer Control CenterJul 07, 2023- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.52
CADD
Benign
22
DANN
Benign
0.78

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs55747230; hg19: chr17-29685660; COSMIC: COSV104420390; API